Low serum v-3 and v-6 polyunsaturated fatty acids and other metabolites are associated with poor linear growth in young children from rural Malawi

American Journal of Clinical Nutrition

Volumn 106, Issue 6, 2017, Pages 1490-1499

  Semba, Richard D ^a   Trehan, Indi ^b   Li, Ximin ^c   Salem, Norman ^d   Moaddel, Ruin ^e   Ordiz, M Isabel ^b   Maleta, Kenneth M ^f   Kraemer, Klaus ^c,g   Manary, Mark J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d DSM NUTRITIONAL PRODUCTS   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f UNIVERSITY OF MALAWI   (Malawi)

^g SIGHT AND LIFE   (Switzerland)

Author keywords

Arachidonic acid; Carnitine; Dehydroepiandrosterone; Docosahexaenoic acid; Malnutrition; Pregnenolone sulfate; Stunting

Indexed keywords

AMINO ACID DERIVATIVE; BIOLOGICAL MARKER; CARNITINE; CIGARETTE SMOKE; GLUTATHIONE; NEUROSTEROID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

AMINO ACID METABOLISM; ARTICLE; BRAIN DEVELOPMENT; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENERGY YIELD; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALAWI; MALE; METABOLITE; METABOLOMICS; PASSIVE SMOKING; RURAL AREA; STUNTING; BLOOD; BODY HEIGHT; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; GROWTH DISORDER; INFANT; LIPID METABOLISM; METABOLISM; NUTRITIONAL STATUS; PRESCHOOL CHILD; RURAL POPULATION;

BODY HEIGHT; CARNITINE; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GLUTATHIONE; GROWTH DISORDERS; HUMANS; INFANT; LIPID METABOLISM; MALAWI; MALE; METABOLIC NETWORKS AND PATHWAYS; NEUROTRANSMITTER AGENTS; NUTRITIONAL STATUS; RURAL POPULATION; TOBACCO SMOKE POLLUTION;

EID: 85038130250     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.117.164384     Document Type: Article

References (57)

1. UNICEF/WHO/World Bank Group. Levels and trends in child malnutrition: key findings of the 2017 edition [Internet]. c2017 [cited 2017 Jun 30]. Available from: http://www.who.int/nutgrowthdb/jme_brochure2017.pdf.
2. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B; International Child Development Steering Group. Developmental potential in the first 5 years for children in developing countries. Lancet 2007;369:60–70.
3. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, Sachdev HS; Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008;371:340–57.
4. Olofin I, McDonald CM, Ezzati M, Flaxman S, Black RE, Fawzi WW, Caulfield LE, Danaei G. Nutrition Impact Model Study (anthropometry cohort pooling). Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies. PLoS One 2013;8:e64636.
5. Hoddinott J, Behrman JR, Maluccio JA, Melgar P, Quisumbing AR, Ramirez-Zea M, Stein AD, Yount KM, Martorell R. Adult consequences of growth failure in early childhood. Am J Clin Nutr 2013;98: 1170–8.
6. Sudfeld CR, McCoy DC, Danaei G, Fink G, Ezzati M, Andrews KG, Fawzi WW. Linear growth and child development in low- and middle-income countries: a meta-analysis. Pediatrics 2015;135:e1266–75.
7. de Onis M, Dewey KG, Borghi E, Onyango AW, Blössner M, Daelmans B, Piwoz E, Branca F. The World Health Organization’s global target for reducing childhood stunting by 2025: rationale and proposed actions. Matern Child Nutr 2013;9(Suppl 2):6–26.
8. Murray CJ. Shifting to sustainable development goals–implications for global health. N Engl J Med 2015;373:1390–3.
9. Black MM, Walker SP, Fernald LCH, Andersen CT, DiGirolamo AM, Lu C, McCoy DC, Fink G, Shawar YR, Shiffman J, et al.; Lancet Early Childhood Development Series Steering Committee. Early childhood development coming of age: science through the life course. Lancet 2017;389:77–90.
10. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, et al.; Maternal and Child Nutrition Study Group. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013;382:427–51.
11. Mayo-Wilson E, Junior JA, Imdad A, Dean S, Chan XH, Chan ES, Jaswal A, Bhutta ZA. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev 2014:CD009384.
12. Adu-Afarwuah S, Lartey A, Okronipa H, Ashorn P, Peerson JM, Arimond M, Ashorn U, Zeilani M, Vosti S, Dewey KG. Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial. Am J Clin Nutr 2016; 104:797–808.
13. Christian P, Shaikh S, Shamim AA, Mehra S, Wu L, Mitra M, Ali H, Merrill RD, Choudhury N, Parveen M, et al. Effect of fortified complementary food supplementation on child growth in rural Bangladesh: a cluster-randomized trial. Int J Epidemiol 2015;44:1862–76.
14. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, Webb P, Lartey A, Black RE; Lancet Nutrition Interventions Review Group, Maternal and Child Nutrition Study Group. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013;382:452–77.
15. Ghosh S, Suri D, Uauy R. Assessment of protein adequacy in developing countries: quality matters. Br J Nutr 2012;108(Suppl 2):S77–87.
16. Semba RD, Shardell M, Sakr Ashour FA, Moaddel R, Trehan I, Maleta KM, Ordiz MI, Kraemer K, Khadeer MA, Ferrucci L, et al. Child stunting is associated with low circulating essential amino acids. EBioMedicine 2016;6:246–52.
17. Semba RD, Zhang P, Gonzalez-Freire M, Moaddel R, Trehan I, Maleta KM, Ordiz MI, Ferrucci L, Manary MJ. The association of serum choline with linear growth failure in young children from rural Malawi. Am J Clin Nutr 2016;104:191–7.
18. Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, Banning F, Seissler J, Grallert H, Adamski J, Lechner A. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. PLoS One 2014;9:e89728.
19. Yin P, Peter A, Franken H, Zhao X, Neukamm SS, Rosenbaum L, Lucio M, Zell A, Häring HU, Xu G, et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem 2013;59:833–45.
20. Evans AM, Bridgewater BR, Liu Q, Mitchell MW, Robinson RJ, Dai H, Stewart SJ, DeHaven CD, Miller LAD. High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics 2014;4:132.
21. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2010;2:9.
22. Storey JD. A direct approach to false discovery rates. J R Stat Soc B 2002;64:479–98.
23. Storey JD, Taylor JE, Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: a unified approach. J R Stat Soc B 2004;66:187–205.
24. Rachakonda V, Gabbert C, Raina A, Bell LN, Cooper S, Malik S, Behari J. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PLoS One 2014;9:e113860.
25. Kim S. ppcor: partial and semi-partial (part) correlation. R package version 1.1 [Internet]. c2015 [cited 2017 Jun 30]. Available from: https://CRAN.R-project.org/package=ppcor.
26. Schafer J, Opgen-Rhein R, Zuber, V, Ahdesmaki M, Duarte Silva AP, Strimmer K. corpcor: efficient estimation of covariance and (partial) correlation. R package version 1.6.8 [Internet]. c2015 [cited 2017 Jun 30]. Available from: https://CRAN.R-project.org/package=corpcor.
27. Storey JD, Bass AJ, Dabney A, Robinson D. qvalue: q-value estimation for false discovery rate control. R package version 2.6.0 [Internet]. c2015 [cited 2017 Jun 2017]. Available from: https://github.com/StoreyLab/qvalue.
28. Best CM, Sun K, de Pee S, Sari M, Bloem MW, Semba RD. Paternal smoking and increased risk of child malnutrition among families in rural Indonesia. Tob Control 2008;17:38–45.
29. Best CM, Sun K, de Pee S, Bloem MW, Stallkamp G, Semba RD. Parental tobacco use is associated with increased risk of child malnutrition in Bangladesh. Nutrition 2007;23:731–8.
30. Semba RD, Campbell AA, Sun K, de Pee S, Akhter N, Moench-Pfanner R, Rah JH, Badham J, Kraemer K, Bloem MW. Paternal smoking is associated with greater food insecurity among poor families in rural Indonesia. Asia Pac J Clin Nutr 2011;20:618–23.
31. Forsyth S, Gautier S, Salem N Jr. Global estimates of dietary intake of docosahexaenoic acid and arachidonic acid in developing and developed countries. Ann Nutr Metab 2016;68:258–67.
32. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993;90:1073–7.
33. Forsyth S, Gautier S, Salem N Jr. Dietary intakes of arachidonic acid and docosahexaenoic acid in early life - with a special focus on complementary feeding in developing countries. Ann Nutr Metab 2017;70:217–27.
34. Colombo J, Carlson SE, Cheatham CL, Shaddy DJ, Kerling EH, Thodosoff JM, Gustafson KM, Brez C. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr 2013;98:403–12.
35. Harauma A, Yasuda H, Hatanaka E, Nakamura MT, Salem N Jr., Moriguchi T. The essentiality of arachidonic acid in addition to docosahexaenoic acid for brain growth and function. Prostaglandins Leukot Essent Fatty Acids 2017;116:9–18.
36. Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N Jr. The essentiality of arachidonic acid in infant development. Nutrients 2016;8: 216.
37. Salem N Jr., Wegher B, Mena P, Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA 1996;93:49–54.
38. Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 2010;186:113–37.
39. Harteneck C. Pregnenolone sulfate: from steroid metabolite to TRP channel ligand. Molecules 2013;18:12012–28.
40. de Menezes KJ, Peixoto C, Nardi AE, Carta MG, Machado S, Veras AB. Dehydroepiandrosterone, its sulfate and cognitive functions. Clin Pract Epidemiol Ment Health 2016;12:24–37.
41. Stárka L, Dusková M, Hill M. Dehydroepiandrosterone: a neuroactive steroid. J Steroid Biochem Mol Biol 2015;145:254–60.
42. Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA. The regulation of steroid action by sulfation and desulfation. Endocr Rev 2015; 36:526–63.
43. Demarquoy J, Georges B, Rigault C, Royer MC, Clairet A, Soty M, Lekounoungou S, Le Borgne F. Radioisotopic determination of L-carnitine content in foods commonly eaten in Western countries. Food Chem 2004;86:137–42.
44. Semba RD, Trehan I, Li X, Moaddel R, Ordiz MI, Maleta KM, Kraemer K, Shardell M, Ferrucci L, Manary M. Environmental enteric dysfunction is associated with carnitine deficiency and altered fatty acid oxidation. EBioMedicine 2017;17:57–66.
45. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916–21.
46. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263–355.
47. Wu G. Amino acids: biochemistry and nutrition. Boca Raton (FL): CRC Press; 2013.
48. Balsom PD, Söderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med 1994;18:268–80.
49. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol 1981;51:762–6.
50. Gjaltema RA, Bank RA. Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease. Crit Rev Biochem Mol Biol 2017;52:74–95.
51. Mattes W, Yang X, Orr MS, Richter P, Mendrick DL. Biomarkers of tobacco smoke exposure. Adv Clin Chem 2014;67:1–45.
52. Cross AJ, Boca S, Freedman ND, Caporaso NE, Huang WY, Sinha R, Sampson JN, Moore SC. Metabolites of tobacco smoking and co-lorectal cancer risk. Carcinogenesis 2014;35:1516–22.
53. Zierer J, Kastenmüller G, Suhre K, Gieger C, Codd V, Tsai PC, Bell J, Peters A, Strauch K, Schulz H, et al. Metabolomics profiling reveals novel markers for leukocyte telomere length. Aging (Albany NY) 2016;8:77–94.
54. Brathwaite R, Addo J, Smeeth L, Lock K. A systematic review of tobacco smoking prevalence and description of tobacco control strategies in sub-Saharan African Countries; 2007 to 2014. PLoS One 2015; 10:e0132401.
55. Gibbs K, Collaco JM, McGrath-Morrow SA. Impact of tobacco smoke and nicotine exposure on lung development. Chest 2016;149:552–61.
56. Raghuveer G, White DA, Hayman LL, Woo JG, Villafane J, Celermajer D, Ward KD, de Ferranti SD, Zachariah J; American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in the Young of the Council on Cardiovascular Disease in the Young. Behavior change for improving health factors committee of the council on lifestyle and cardiometabolic health and council on epidemiology and prevention; and stroke council. Cardiovascular consequences of childhood secondhand tobacco smoke exposure: prevailing evidence, burden, and racial and socioeconomic disparities: a scientific statement from the American Heart Association. Circulation 2016;134:e336–59.
57. Iannotti LL, Lutter CK, Stewart CP, Gallegos Riofrío CA, Malo C, Reinhart G, Palacios A, Karp C, Chapnick M, Cox K, et al. Eggs in early complementary feeding and child growth: a randomized controlled trial. Pediatrics 2017;140:e20163459.